₹74.50
+₹0.91 (+1.24%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹265 Cr
P/E
-28.24
ROE
-10.86%
ROCE
-6.04%
About Lyka Labs Ltd
Lyka Labs is engaged in the business of pharmaceutical and related activities, including research.
Founded
1976
CEO
Babulal Jain
Employees
648
HQ
Mumbai, India
About Lyka Labs Ltd
Lyka Labs is engaged in the business of pharmaceutical and related activities, including research.
Founded:1976
CEO:Babulal Jain
Employees:648
HQ:Mumbai, India
Finished Products
1Sales
₹346.65Cr2Formulations
₹220.08Cr3Processing & Labour Charges
₹15.95Cr4Bulk Drugs
₹11.00Cr5Processing Charges Received
₹3.62Cr6Commission
₹3.20Cr7Other Operating Revenues
₹2.47Cr1–7 of 9
Raw Materials
1Raw Material Consumed
₹124.06Cr2Purchase of Finished Products
₹36.30Cr3Purchases of Stock in Trade
₹14.80CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹103
52W Low
₹44
Volume16.41K
Avg VolumeN/A
Beta1.14
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-28.24x
Valuation
P/B Ratio
2.86x
Valuation
EPS
₹-2.60
Valuation
Dividend Yield
0.00%
Valuation
ROE
-10.86%
Profitability
ROCE
-6.04%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical products/Pharma relaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
68.8%
International
31.2%
Domestic68.8%
Exports31.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.53x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.